Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD

Open access

Abstract

Context: Although type 2 diabetes (T2D) is a risk factor for liver fibrosis in nonalcoholic fatty liver disease (NAFLD), the specific contribution of insulin resistance (IR) relative to other factors is unknown. Objective: Assess the impact on liver fibrosis in NAFLD of adipose tissue (adipose tissue insulin resistance index [adipo-IR]) and liver (Homeostatic Model Assessment of Insulin Resistance [HOMA-IR]) IR in people with T2D and NAFLD. Design: Participants were screened by elastography in the outpatient clinics for hepatic steatosis and fibrosis, including routine metabolites, cytokeratin-18 (a marker of hepatocyte apoptosis/steatohepatitis), and HOMA-IR/adipo-IR. Setting: University ambulatory care practice. Participants: A total of 483 participants with T2D. Intervention: Screening for steatosis and fibrosis with elastography. Main outcome measures: Liver steatosis (controlled attenuation parameter), fibrosis (liver stiffness measurement), and measurements of IR (adipo-IR, HOMA-IR) and fibrosis (cytokeratin-18). Results: Clinically significant liver fibrosis (stage F ≥ 2 = liver stiffness measurement ≥8.0 kPa) was found in 11%, having more features of the metabolic syndrome, lower adiponectin, and higher aspartate aminotransferase (AST), alanine aminotransferase, liver fat, and cytokeratin-18 (P < 0.05-0.01). In multivariable analysis including just clinical variables (model 1), obesity (body mass index [BMI]) had the strongest association with fibrosis (odds ratio, 2.56; CI, 1.87-3.50; P < 0.01). When metabolic measurements and cytokeratin-18 were included (model 2), only BMI, AST, and liver fat remained significant. When fibrosis stage was adjusted for BMI, AST, and steatosis (model 3), only Adipo-IR remained strongly associated with fibrosis (OR, 1.51; CI, 1.05-2.16; P = 0.03), but not BMI, hepatic IR, or steatosis. Conclusions: These findings pinpoint to the central role of dysfunctional, insulin-resistant adipose tissue to advanced fibrosis in T2D, beyond simply BMI or steatosis. The clinical implication is that targeting adipose tissue should be the priority of treatment in NAFLD.

Overview

Integrity signals

Registry

Crossref · 10.1210/clinem/dgac660

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

See all 64

Metadata

Authors
Kalavalapalli, S., Leiva, E. G., Lomonaco, R., Chi, X., Shrestha, S., Dillard, R., Budd, J., Romero, J. P., Li, C., Bril, F., Samraj, G., Pennington, J., Townsend, P., Orlando, F., Shetty, S., Mansour, L., Silva-Sombra, L. R., Bedossa, P., Malaty, J., Barb, D., Gurka, M. J., & Cusi, K.
Affiliations
  • University of Florida Health (US)
  • Division of General Internal Medicine, University of Florida , Gainesville, FL 32606 , USA
  • University of Florida (US)
  • Publique-Hôpitaux de Paris, Beaujon Hospital, Pathology Department and University Paris-Diderot , 75116 Paris , France
Corresponding author
Cusi, Kenneth
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2022-11-16
Volume
108
Issue
5
Pages
1192-1201
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4309161291
Cited by
64
References
31
Citations by year
2026: 19 · 2025: 20 · 2024: 17 · 2023: 8
FWCI
8.12
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Echosens
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
adipose tissue insulin resistance, liver fibrosis, type 2 diabetes, non-alcoholic fatty liver disease, HOMA-IR, hepatic steatosis, cytokeratin 18, liver stiffness measurement, controlled attenuation parameter, obesity, adiponectin, metabolic syndrome, hepatocyte apoptosis, elastography, fibrosis severity prediction, hepatic insulin resistance, aspartate aminotransferase
MeSH terms
Adipose Tissue, Diabetes Mellitus, Type 2, Fibrosis, Humans, Insulin, Insulin Resistance, Liver, Liver Cirrhosis, Keratin-18, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD. https://app.cochat.ai/papers/10.1210/clinem/dgac660
The paper
Kalavalapalli, S., Leiva, E. G., Lomonaco, R., Chi, X., Shrestha, S., Dillard, R., Budd, J., Romero, J. P., Li, C., Bril, F., Samraj, G., Pennington, J., Townsend, P., Orlando, F., Shetty, S., Mansour, L., Silva-Sombra, L. R., Bedossa, P., Malaty, J., . . . Cusi, K. (2023). Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac660

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.